Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark g.y.h.lip@bham.ac.uk.
Gregory Y H
GY
Lip
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
Deirdre A
DA
Lane
D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009915:Orbit; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke
D000925:Anticoagulants